DailyIQ
Last updated 1 hour ago

PATH·UiPath Inc

$.
-. (-.%)
High
$11.10
Open
$10.96
Market Cap
5.69B
52W High
$19.84
Low
$10.73
P. Close
$10.93
P/E
20.15
52W Low
$9.20
Fwd P/E
12.15
Mean Target
-
Technical Score (1D)
27
SELL
News Sentiment
74
BULLISH
UiPath has expanded its collaboration with Deloitte, integrating UiPath Test Cloud into Deloitte's Ascend platform. This integration leverages agentic AI to automate software testing, enabling autonomous quality assurance where AI agents work alongside human testers. The partnership aims to accelerate development, testing, and deployment cycles, potentially leading to faster software delivery and improved automation efficiency. This development matters for the next 1-10 trading days as it signals a deeper commitment to AI-driven solutions in the enterprise software space. Investors will be watching for any early indicators of adoption and impact on UiPath's revenue streams.
Earnings Summary
UiPath Inc. operates in the Software - Infrastructure industry within the Technology sector, providing a comprehensive automation platform that leverages robotic process automation (RPA) with integrated AI and machine learning capabilities. The company aims to streamline business operations by automating repetitive tasks for organizations across various industries. In its most recent reported quarters, Q2 2025 saw actual EPS of $0.15 against an estimate of $0.08, and Q3 2025 reported EPS of $0.16 against an estimate of $0.15. Both quarters represent EPS beats. Revenue for Q2 2025 was $361.73 million and for Q3 2025 was $411.11 million, with revenue estimates not provided for these specific quarters. Looking at the prior two quarters, Q4 2024 reported EPS of $0.26 versus an estimate of $0.19, and Q1 2025 reported EPS of $0.11 against an estimate of $0.10. Both of these quarters also showed EPS beats. Historically, UiPath has shown a consistent pattern of beating analyst estimates for EPS, indicating strong performance relative to expectations. Recent news highlights the expansion of its agentic AI capabilities with on-premises deployment options for government and regulated industries, addressing data sovereignty needs. However, the stock has recently underperformed broader market indices, with concerns about decelerating demand and softening customer interest noted, alongside high short interest contributing to volatility. Investors should watch for the adoption and revenue impact of its new agentic AI capabilities, the company's ability to demonstrate sustained growth against decelerating demand signals, and how market sentiment evolves regarding its AI strategy and valuation. The partnership with Deloitte and validation by Databricks are also key developments to monitor.

EPS

EstBeatMiss
$0.05$0.12$0.19$0.26$0.33Q4'24Q1'25Q2'25Q3'25Q4'26Q1'27
QtrEstActual+/−
Q1'27$0.16 - -
Q4'26$0.26$0.30+15.5%
Q3'25$0.15$0.16+9.6%
Q2'25$0.08$0.15+79.8%
Q1'25$0.10$0.11+7.2%
Q4'24$0.19$0.26+34.0%

Revenue

EstBeatMiss
$338M$378M$419M$459M$500MQ4'24Q1'25Q2'25Q3'25Q4'26Q1'27
QtrEstActual+/−
Q1'27$406M - -
Q4'26$474M$481M+1.5%
Q3'25 - $411M -
Q2'25 - $362M -
Q1'25 - $357M -
Q4'24 - $424M -

Market Data

PATH Stock Snapshot

PATH is currently trading at $10.83, giving UiPath Inc a market cap of 5.69B and a P/E ratio of 20.1. Today's range spans $10.73–$11.10, with shares opening at $10.96 and moving down $0.10 (0.9%) from the prior close. DailyIQ's technical score sits at 27/100 (SELL) with a news sentiment reading of 74/100.

Over the past year PATH has traded between $9.20 and $19.84 - the current price is +17.7% off the 52-week low and -45.4% from the high.

Liquidity risk is the overlooked factor in PATH's non-bullish setup (27/100, SELL): at 5.69B in Technology market cap, bid-ask spreads widen when sentiment is bullish (74/100) and technical momentum is absent. Price: $10.83 (near 52-week lows in $9.20–$19.84). The current P/E ratio stands at 20.1. The exit costs in a thin-float small-cap stock with deteriorating technical conditions are materially higher than in larger-cap equivalents - a dynamic that risk managers typically account for before the technicals get worse, not after.

Small-cap Technology names with SELL technicals (27/100) and bullish sentiment (74/100) like PATH tend to experience sentiment-driven re-ratings more sharply in both directions. At $10.83 (near 52-week lows in $9.20–$19.84), the current setup suggests a stock that needs a material positive catalyst — not incremental improvement — to reverse the technical and sentiment readings that now define the 5.69B market cap trajectory.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles
Loading latest news…